Xenon xe 127
Xenon xe 127 is a small molecule pharmaceutical. Xenon xe 127 was first approved as Xenon xe 127 on 1982-10-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Xenon xe-127
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| XENON XE 127 | Mallinckrodt | N-018536 DISCN | 1982-10-01 | 2 products |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| xenoview | New Drug Application | 2022-12-30 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
91 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Vulvovaginal candidiasis | D002181 | EFO_0007543 | B37.3 | 1 | 3 | 3 | 5 | 1 | 11 |
| Bacterial vaginosis | D016585 | EFO_0003932 | 1 | 1 | 1 | 1 | 1 | 5 | |
| Candidiasis | D002177 | B37 | — | 1 | 2 | 1 | — | 4 | |
| Invasive fungal infections | D000072742 | — | — | — | 1 | 2 | 3 | ||
| Onychomycosis | D014009 | B35.1 | — | — | — | 1 | 1 | 2 | |
| Hyperlipoproteinemia type ii | D006938 | EFO_0004911 | E78.00 | — | — | — | 1 | — | 1 |
| Burns | D002056 | T30.0 | — | — | — | 1 | — | 1 | |
| Atopic dermatitis | D003876 | EFO_0000274 | L20 | — | — | — | 1 | — | 1 |
| Eczematous skin diseases | D017443 | — | — | — | 1 | — | 1 | ||
| Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | — | — | 1 | — | 1 |
Show 2 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Mycoses | D009181 | B35-B49 | — | 2 | 3 | — | 2 | 6 | |
| Otomycosis | D059249 | — | 2 | 3 | — | 2 | 6 | ||
| Oral candidiasis | D002180 | EFO_0007406 | B37.0 | — | 1 | 2 | — | 1 | 4 |
| Tinea pedis | D014008 | EFO_0007512 | B35.3 | 3 | — | 1 | — | — | 4 |
| Hiv infections | D015658 | EFO_0000764 | B20 | — | — | 2 | — | 1 | 3 |
| Tinea | D014005 | EFO_0007510 | B35.4 | — | — | 2 | — | — | 2 |
| Tinea cruris | D000084002 | B35.6 | — | 1 | 1 | — | — | 2 | |
| Denture stomatitis | D013282 | EFO_1000893 | K12.1 | — | 1 | 1 | — | — | 2 |
| Intraabdominal infections | D059413 | — | — | 1 | — | — | 1 | ||
| Folliculitis | D005499 | — | 1 | 1 | — | — | 1 |
Show 4 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Invasive pulmonary aspergillosis | D055744 | B44.0 | — | 1 | — | — | 2 | 3 | |
| Sickle cell anemia | D000755 | EFO_0000697 | D57 | 1 | 1 | — | — | 1 | 2 |
| Myelodysplastic syndromes | D009190 | D46 | — | 1 | — | — | 1 | 2 | |
| Stomatitis | D013280 | EFO_1001904 | K12.1 | — | 2 | — | — | — | 2 |
| Neoplasms | D009369 | C80 | — | 1 | — | — | — | 1 | |
| Leukemia | D007938 | C95 | — | 1 | — | — | — | 1 | |
| Hematologic neoplasms | D019337 | — | 1 | — | — | — | 1 | ||
| Graft vs host disease | D006086 | D89.81 | — | 1 | — | — | — | 1 | |
| Kidney diseases | D007674 | EFO_0003086 | N08 | 1 | 1 | — | — | — | 1 |
| Kidney transplantation | D016030 | 1 | 1 | — | — | — | 1 |
Show 7 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Invasive candidiasis | D058365 | EFO_1001283 | B37 | — | — | — | — | 1 | 1 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | — | — | — | 1 | 1 |
| Invasive hydatidiform mole | D002820 | D39.2 | — | — | — | — | 1 | 1 | |
| Fusariosis | D060585 | EFO_1001795 | — | — | — | — | 1 | 1 | |
| Hypercholesterolemia | D006937 | HP_0003124 | — | — | — | — | 1 | 1 | |
| Corneal ulcer | D003320 | H16.0 | — | — | — | — | 1 | 1 | |
| Sepsis | D018805 | A41.9 | — | — | — | — | 1 | 1 | |
| Laser therapy | D053685 | — | — | — | — | 1 | 1 | ||
| Lichen planus | D008010 | L43 | — | — | — | — | 1 | 1 | |
| Recurrence | D012008 | — | — | — | — | 1 | 1 |
Show 2 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | XENON XE 127 |
| INN | — |
| Description | Xenon xe 127 is a small molecule pharmaceutical. Xenon xe 127 was first approved as Xenon xe 127 on 1982-10-01. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | [127Xe] |
Identifiers
| PDB | — |
| CAS-ID | 13994-19-9 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1200673 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 289 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1,748 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more